MedPath

Effects of Fish Oil on Platelet Function and Coagulation

Not Applicable
Completed
Conditions
Platelet Aggregation, Spontaneous
Atherosclerosis
Surgery
Interventions
Registration Number
NCT03048981
Lead Sponsor
Region Skane
Brief Summary

Many patients undergoing surgery use naturopathic drugs, including fish oil. Fish oil has been reported to increase bleeding in patients through inhibiting platelet aggregation and prolonging of clot formation time. The Swedish Medical Products Agency recommends that patients stop taking the naturopathic medicines including fish oil two weeks prior planed surgery. The aim of this study is to examine the effects of fish oil given to healthy volunteers using point of care coagulation assessment and flow dependent Cellix instrument before and after intake of fish oil.

Detailed Description

Healthy volunteers will be given maximum dose of fish oil for 7 days. Blood samples will be collected before and immediately after the 7 days of intake and analysed using point of care coagulation assessment instruments and flow dependent platelet aggregation using a microfluid flow controlled system (Cellix). For point of care coagulation assessment the multiple electrode platelet aggregometer Multiplate, the viscoelastic rotational thromboelastometers ROTEM and Sonoclot will be used. Flow cytometry may also be utilized.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • Non smoking healthy volunteers with written consent to participate
Exclusion Criteria
  • Medication affecting coagulation or platelets within 14 days priori to inclusion

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Fish oil intakeFish oilHealthy volunteers given maximum dose of fish oil for 10 days.
Primary Outcome Measures
NameTimeMethod
Thrombocyte aggregation measured with Cellix's microfluidic pumps and biochipsChange of thrombocyte aggregation directly after intake period of 7 days compared to baseline

Cellix's microfluidic pumps and biochips gives an thrombosis area proportional to thrombocyte aggregation

Thrombocyte aggregation measured with multiple electrode aggregometryChange of thrombocyte aggregation directly after intake period of 7 days compared to baseline

Multiple electrode aggregometry gives a area under the curve proportional to thrombocyte aggregation

Secondary Outcome Measures
NameTimeMethod
Coagulation measured with the viscohemostatic instrument and SonoclotChange of coagulation directly after intake period of 7 days compared to baseline

Viscohemostatic instrument

Coagulation measured with the viscohemostatic instrument ROTEMChange of coagulation directly after intake period of 7 days compared to baseline

Viscohemostatic instrument

Trial Locations

Locations (1)

Intensive and perioperative care. Skåne University Hospital. Lund

🇸🇪

Lund, Skåne, Sweden

© Copyright 2025. All Rights Reserved by MedPath